Menu

Clinical trials offer patients access to the latest breakthroughs

When Shari Pimental underwent routine surgery two years ago to remove her gallbladder, she woke up in the recovery room and learned she had stage III ovarian cancer.

Dr. Kathleen Yang, Shari's gynecologic oncologist at Willamette Valley Cancer Institute, thought Shari could possibly benefit from a clinical trial at WVCI for an investigational drug, classified as a PARP inhibitor that's designed to block specific enzymes that cancer cells need to survive.

By | December 20th, 2017|Blog, Clinical Trials, Targeting Cancer|

Breast Cancer patient rallies support for Oregon Cancer Foundation

When Brenda Mills of Springfield was diagnosed with stage 2 triple negative breast cancer in June of 2016, she knew she was in for the fight of her life, physically and mentally. What she didn't expect was that cancer would also cost a financial toll. When she needed support, the Oregon Cancer Foundation was there to help.

New device now available at WVCI to treat brain cancer patients

Jim Ketter, a former physics instructor at Oregon State University is among the first in the Willamette Valley to receive a new treatment for glioblastoma, the most common type of brain tumor in adults. Jim underwent surgery and radiation therapy, and now, in addition to receiving chemotherapy, he wears a cap-like device called Optune.

By | September 26th, 2017|Blog, Inside WVCI, Targeting Cancer|

Light the Grill fundraiser supports blood cancer research

Jeff Gusinow spent part of the summer doing something he hadn't planned: receiving treatment at Willamette Valley Cancer Institute. "I write on my Facebook page every week about how my 'staycation' is going, as if I were on a boat. So, this is the leido deck," Jeff says from where he sits in WVCI's infusion room. Jeff was diagnosed 11 years ago with a slow-growing blood cancer called follicular lymphoma, the most common form of Non-Hodgkin lymphoma. His cancer has now advanced to the point where treatment is recommended.

By | August 29th, 2017|Blog, Patient Stories, Targeting Cancer|
Load More Posts